See the DrugPatentWatch profile for Lamzede
What is Lamzede, and what is it used for?
Lamzede is the brand name for alglucosidase alfa-gntb, an enzyme replacement therapy used to treat late-onset Pompe disease (a lysosomal storage disorder caused by acid alpha-glucosidase deficiency). [1]
How does Lamzede work?
Pompe disease happens when the body cannot break down glycogen properly. Lamzede provides a manufactured version of the missing enzyme (alglucosidase alfa-gntb) so the body can degrade stored glycogen in cells. [1]
How is Lamzede given?
Lamzede is given as an intravenous infusion (through a vein). [1]
What side effects do patients report or clinicians monitor for?
The most important risks are generally related to infusion reactions and immune responses. Commonly monitored effects include reactions during or after infusions, such as hypersensitivity/allergic-type responses. [1]
Who makes Lamzede, and is it available as a generic?
Lamzede is a branded biologic. Whether a specific “generic” is available depends on regulatory approvals and biosimilar status in a given country; biosimilars are not automatically interchangeable with brands without specific approval and guidance. [1]
Where can I find official dosing and prescribing details?
Prescribing information and regulatory documents (including dosing, infusion preparation, warnings, and monitoring guidance) are the best reference for a patient’s situation and country-specific labeling. [1]
---
Sources
[1] https://www.drugs.com/lamzede.html